# venBio Partners' Biotech Investments: 11 Startups in Its Portfolio (2026) > The 11 Biotech startups venBio Partners has backed, by stage: $1.9B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/venbio-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 7 - [Akero Therapeutics](https://millionrounds.com/company/akero-therapeutics) - [*CT* Cidara Therapeutics](https://millionrounds.com/company/cidara-therapeutics) - [Pharvaris](https://millionrounds.com/company/pharvaris) - [Arrakis Therapeutics](https://millionrounds.com/company/arrakis-therapeutics) - [NeuroGastrx](https://millionrounds.com/company/neurogastrx) - [Vicebio](https://millionrounds.com/company/vicebio) - [Checkmate Pharmaceuticals](https://millionrounds.com/company/checkmate-pharmaceuticals) ## Series C and later 4 - [Metacrine](https://millionrounds.com/company/metacrine) - [Aragon Pharmaceuticals](https://millionrounds.com/company/aragon-pharmaceuticals) - [*IN* Impel NeuroPharma](https://millionrounds.com/company/impel-neuropharma) - [*SH* Swift Health Systems](https://millionrounds.com/company/swift-health-systems) ## Segment by segment ### Series B 7 startups · $1.5B raised - [**Akero Therapeutics**](https://millionrounds.com/company/akero-therapeutics) Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state. United States $502M - [*CT* **Cidara Therapeutics**](https://millionrounds.com/company/cidara-therapeutics) Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics. United States $463M - [**Pharvaris**](https://millionrounds.com/company/pharvaris) Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients. Switzerland $132M - [**Arrakis Therapeutics**](https://millionrounds.com/company/arrakis-therapeutics) Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases. United States $113M - [**NeuroGastrx**](https://millionrounds.com/company/neurogastrx) A private biopharmaceutical company. United States $105M - [**Vicebio**](https://millionrounds.com/company/vicebio) Vicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology. United Kingdom $100M - [**Checkmate Pharmaceuticals**](https://millionrounds.com/company/checkmate-pharmaceuticals) Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy. United States $69M ### Series C and later 4 startups · $447M raised - [**Metacrine**](https://millionrounds.com/company/metacrine) Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs. United States $173M - [**Aragon Pharmaceuticals**](https://millionrounds.com/company/aragon-pharmaceuticals) Aragon Pharmaceuticals develops therapeutics for the treatment of hormone-resistant cancers such as prostate and breast cancer. United States $122M - [*IN* **Impel NeuroPharma**](https://millionrounds.com/company/impel-neuropharma) United States $107M - [*SH* **Swift Health Systems**](https://millionrounds.com/company/swift-health-systems) United States $45M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names venBio Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with venBio Partners** 20 co-investors](https://millionrounds.com/portfolio-maps/venbio-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)[Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio)[Sector portfolio **Sequoia Capital's AI portfolio** 209 startups · $543B](https://millionrounds.com/portfolio-maps/sequoia-capital-ai-portfolio) ## Raising from investors like venBio Partners? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)